The anti-cathepsin B antibody was from Abcam (Cambridge, UK), the anti-Na+/K+-ATPase antibody was from MilliporeSigma (Burlington, MA, USA), and the anti-GAPDH and β-tubulin antibodies were from Cell Signaling Technology, Inc (Dover, MA, USA). LipidORDERTM [31 (link)] was purchased from DiagnoCine (Hackensack, NJ, USA). LysoPrime GreenTM was from Dojindo Molecular Technologies, Inc (Rockville, MD, USA). 4-hydroxy-2-nonenal (HNE) and L-leucyl-L-leucine methyl ester (LLOMe) were purchased from MilliporeSigma. The AAV packaging the C99 YPet-TurquoiseGL (C99 Y-T) [20 (link)] was developed using University of Pennsylvania Gene Therapy Program vector core (Philadelphia, PA, USA; 4.95 × 1013 GC/mL).
Free full text: Click here